PALO ALTO, Calif., Jan. 25, 2021 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc (Nasdaq:EIGR), a commercial-stage biopharmaceutical company focused on the development and commercialization of ...

PALO ALTO, Calif., March 17, 2022 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies to treat ...

Eiger BioPharmaceuticals, Inc. EIGR is a biopharmaceutical company that could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum, but it is ...

Eiger is solely focused on rare disease opportunities with its big target being hepatitis delta virus. Eiger's first therapy Zokinvy just got approved which nets the company an important Priority ...

One stock that might be an intriguing choice for investors right now is Eiger BioPharmaceuticals, Inc. EIGR. This is because this security in the Medical - Biomedical and Genetics space is seeing ...

The FDA approved Eiger Biopharmaceuticals Inc (NASDAQ:EIGR)'s lonfarnib Friday for the treatment of Hutchinson-Gilford Progeria Syndrome, commonly referred to as progeria, as well as ...

The following is a script from "Taking on the Eiger" which aired on Nov. 29, 2015. Anderson Cooper is the correspondent. Tom Anderson, producer. The Eiger -- in the Swiss Alps -- is one of the most ...

The peak became famous in the 1930s when people would gather to catch glimpses of climbing parties ascending its vertical face THE Eiger – which translates as the Ogre- is is a 13,000ft mountain in ...